AgelessRX Prescribes GLP-1 Medications and Skin Treatments For Youthful Results
It can be harder to lose weight after a certain age, which is why GLP-1 medications can be incredibly useful. That's where ...
HealthDay on MSN5d
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...
Medpage Today on MSN3d
FDA Adds New Warning to GLP-1 Drugs
Labels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep ...
FiercePharma4d
After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy
Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...
Verywell Health on MSN2d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
News Medical1h
GLP-1 and SGLT2 inhibitors show promise in preventing recurrent stroke and heart attack
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
4 Ways to Prevent Muscle Loss on Ozempic & Other Weight Loss GLP-1 Medications
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...
Managed Healthcare Executive4d
GLP-1 Benefits For People With Ulcerative Colitis and Obesity
Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...
News Medical on MSN1h
GLP-1, SGLT2 Drugs Cut Heart Risk for Stroke Survivors
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...